id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-0129-0011,FDA,FDA-2012-N-0129,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approval; General Licensing Provisions; Section 351(k) Biosimilar Applications",Notice,Notice of Approval,2016-02-02T05:00:00Z,2016,2,2016-02-02T05:00:00Z,,2016-02-02T20:22:59Z,2016-01783,0,0,0900006481e44e4f